Over three decades ago, in 1976, the National Cancer Institute performed a study on the soursop fruit (also known as graviola) which demonstrated amazing cancer-fighting potential. Results of this research showed that graviola was quite effective at attacking and destroying the malignant cells.
As a matter of fact, graviola was found to be “selectively toxic” to colon cancer cells and was also calculated to be 10,000 times more potent than Adriamycin chemotherapy (also known as doxorubicin). Adriamycin is oftentimes called “red devil” due to its deep red color and terrible side effects, which include life-threatening (sometimes fatal) damage to the cardiovascular system. Even though Adriamycin is NOT selectively toxic to cancer cells (i.e. it kills ALL cells – even healthy cells), it has been a first choice of chemo for over 50 years.
In 2011, researchers found that graviola fruit extract (GFE) suppressed so-called oncogene (or cancer-causing gene) expression in breast cancer. The oncogene, known as epidermal growth factor receptor, is commonly over-expressed in breast cancer, and therefore an ideal target for therapy.